Skip to content

Able Quote by Francis Collins

“When a drug comes out [that's broadly prescribed] there are going to start to be a lot of people on it [in a million person cohort] and you might get therefore an early signal of something unexpected that hadn't come through in the clinical trials. And I'm sure [drug companies] would love it if…” quote by Francis Collins
Download Open image
“When a drug comes out [that's broadly prescribed] there are going to start to be a lot of people on it [in a million person cohort] and you might get therefore an early signal of something unexpected that hadn't come through in the clinical trials. And I'm sure [drug companies] would love it if, in fact, FDA, recognizing that, would say, OK, maybe you don't have to do your trial with 30,000 people because we're going to find out shortly after registration because we'll have a lot of people taking the drug and we'll be able to see what happened using PMI.”

Francis Collins

About This Quote

Source Speech: Interview on pharmacovigilance, 2015

Large-scale post‑marketing data can reveal rare adverse effects missed in trials.

In simple terms: Real‑world data catches hidden drug risks.

Key Takeaway

Use post‑approval monitoring to ensure safety.

Themes

pharmacovigilance drug safety real‑world evidence

Mood

cautious analytical

Type

educational informative

When to use this quote

  • new drug launch
  • clinical trial design
  • health policy
  • patient safety

Key Concepts

epidemiology signal detection regulatory science

Questions to Reflect On

  • How can we improve data collection after drug approval?
  • What safeguards protect patients before signals emerge?
A Different Perspective

Limited by reporting bias and data quality.

3.4 out of 5 (7 ratings)

More by Francis Collins

Explore all 102 Francis Collins quotes

More Able quotes

Browse all 17,257 Able quotes